About

We believe one solution rests in pursuing scientific areas that remain underexplored and underappreciated. Forging new ground in healthcare requires venturing into these untapped areas, following where the science leads and breaking beyond incremental improvements. This is how we will bring patients first-in-class, safe and effective medicines in cancers where there have been severely limited options. Treadwell is a science-first organization leveraging deep mechanistic insights and cutting-edge tools to uncover novel targets and to translate those insights into clinical candidates.

We house our drug discovery and development efforts under one roof, and much of our world-class team has worked under that roof since our founding, akin to how companies in the early days of the biotechnology industry operated. With this classic-yet-modern approach, there is the potential to address significant unmet needs in oncology and deliver first-in-class treatments that break outside of the incremental mold.